2006 publications supported by the Fungal Research Trust directly or indirectly
Woodcock AA, Steele N, Moore CB, Howard SH, Custovic A, Denning DW, Fungal contamination of bedding. Allergy 2006; 61:140-2.
Hamer EC, Moore CB, Denning DW. Comparison of two fluorescent whiteners, Calcofluor and Blankophor, in the detection of fungal elements in clinical specimens in the diagnostic laboratory. Clin Microbiol Infect 2006;12:181-4.
Warn PA, Sharp A, Denning DW. In Vitro Activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug) against Aspergillus spp.J Antimicrob Chemother 2006;57:135-8.
Sambatakou H, Dupont B. Lode H, Denning DW. Efficacy and safety of voriconazole in the treatment of sub-acute invasive and chronic pulmonary aspergillosis. Am J Med 2006;119:527.e17-24.
Sambatakou H. Pravica V, Hutchinson I, Denning DW. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenetics 2006;33:297-302.
Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006;12:1060-76.
Howard SJ, Walker SL, Andrew SM, Borman AM, Johnson EM, Denning DW. Sub-cutaneous phaeohyphomycosis caused by Cladophialophora devresii in a United Kingdom resident. Med Mycol 2006;44:553-6.
Lass-Florl C, Cuenca-Estrella M, Denning DW, Rodiguez-Tudela, JL. Antifungal susceptibility testing in Aspergillus spp. According to EUCAST methodology. Med Mycol 2006;44(Suppl 1):319-25.
Bowyer P, Blightman O, Denning DW. Relative reactivity and comparative genomic analysis of Aspergillus allergens used in serological tests. Med Mycol 2006;44 (Suppl 1):24-28.
Wortman JR, Fedorova N, Crabtree J, Joardar V, Maiti R, Haas BJ, Amedeo P, Lee E, Angiuoli SV, Jiang B, Anderson MJ, Denning DW, White OR, Nierman WC. Whole genome comparison of the A.fumigatus family. Med Mycol 2006;44(Suppl 1):3-7.
Bowyer P, Fraczek M, Denning DW. A comparative genomic analysis of fungal allergens reveals the presence of multiple cross reactive proteins. BMC Genomics 2006;7:251.
Hope WW, Warn PA, Sharp A, Howard S, Kasai M, Louie A, Walsh TJ, Drusano G, Denning DW. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and impact of the MIC, growth rate, and resistance genotype on the antifungal effect. Antimicrob Ag Chemother. 2006;50:3680-8.
Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, Perlin DS, Denning DW. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Ag 2006;28:450-3.
Warn PA, Sharp A, Mosquera J, Spickermann J, Schmidtt-Hoffmann A, Heep M, Denning DW. Comparative in vivo activity of BAL4815, the active component of the Prodrug BAL8557 in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother 2006;58:1198-207.